Investors & Partners

Current Investors

Private Investors

In addition to Merieux and Shire, Proclara has received funding from private life sciences investors from Europe and the US.


Current Partners

We are actively forging strategic partnerships to accelerate the development of our novel therapies for patients with protein misfolding diseases.

Companies interested in exploring partnering opportunities should contact


Research Partnerships


Clinical Partnerships

ManUfacturing partnerships